Molecular Cytogenetics Unit

Home | Research & Innovation | Scientific Programmes | Human Cancer Genetics Programme | Molecular Cytogenetics Unit

Sandra Rodríguez
Sandra Rodríguez Head of Unit
T +34 917328000 (Ext 3340)
srodriguezp@cnio.es

Staff Scientists

  • Raúl Torres

Graduate Students

  • María Cruz Casado
  • Pilar Puig

Technicians

  • M. Carmen Martín
  • Marta Martínez-Lage
  • Francisco José Moya

Recurrent chromosomal rearrangements – changes in the structure of native chromosomes – are very common and well-known hallmarks of cancer. A better understanding of these cancer-causing mechanisms will lead to novel therapeutic regimens to fight cancer. The research activity of the Molecular Cytogenetics Unit focuses on increasing the knowledge about the role of chromosomal rearrangements in cancer development and progression and the discovery of new therapeutic targets. With the combined use of CRISPR genome editing and cytogenetic technologies, we are creating models that recapitulate chromosomal and genetic cancer alterations. The goal of the Unit is to provide CNIO and external researchers with the latest technologies used in the fields of molecular cytogenetics and genome editing. The Unit is continuously implementing and developing new technologies in those fields. We also participate in collaborative projects with clinical and basic science investigators across the CNIO and other institutions.

Publications

Up